$18.230
+0.253 (+1.39%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TAK Prediction & Forecast by Similar Chart Analysis
Alphio's TAK stock price prediction model matches the current Takeda Pharmaceutical Co Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $18.50 (+1.48%). The 1-week path is $18.97 (+4.08%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Takeda Pharmaceutical Co Ltd Stock?
Takeda Pharmaceutical Co Ltd (TAK) is a good buy right now due to its current price of 18.03, which is below the analyst price target of approximately 46.25 USD (converted from 6,900 yen). Additionally, the forward P/E ratio of 11.236 suggests that the stock is reasonably valued compared to its earnings potential. The recent approval of Takeda's ORZEYFUL for narcolepsy treatment is a significant positive catalyst that could enhance future revenue streams. However, investors should be cautious of the net income fluctuations, particularly the recent loss of 368.47 billion JPY in Q4 2026, which indicates volatility in profitability.
TAK stock price ended at $18.23 on Tuesday, after rising +1.39%
Takeda Pharmaceutical Co Ltd (TAK) last closed at $18.23, gaining +1.39%. These facts feed the 1-day and 1-week TAK price prediction above.
Forecast Drivers
Takeda Pharmaceutical Co Ltd (TAK) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches TAK, ranked by similarity.
Seasonality analysis for TAK
Historically the probability of a positive September return for TAK is 97.62%. September offers the highest probability of a positive month at 97.62%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TAK
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $12.01 | $14.66 | $17.42 | -19.58% |
| Oct 2026 | $14.50 | $17.26 | $18.76 | -5.33% |
| Nov 2026 | $14.53 | $15.84 | $18.46 | -13.12% |
| Dec 2026 | $14.78 | $16.05 | $18.07 | -11.97% |
In 2026, Takeda Pharmaceutical Co Ltd (TAK) is projected to range from $12.01 to $18.76.
Takeda Pharmaceutical Co Ltd 2026 monthly forecast
In Sep 2026, Takeda Pharmaceutical Co Ltd is projected to average $14.66, with a low of $12.01 and high of $17.42.
In Oct 2026, Takeda Pharmaceutical Co Ltd is projected to average $17.26, with a low of $14.50 and high of $18.76.
In Nov 2026, Takeda Pharmaceutical Co Ltd is projected to average $15.84, with a low of $14.53 and high of $18.46.
In Dec 2026, Takeda Pharmaceutical Co Ltd is projected to average $16.05, with a low of $14.78 and high of $18.07.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.